AtaiBeckley ATAI
NASDAQ ATAI
$7.40 +0.06 (+0.82%)
As of: Sep 4, 2026 · 3:17 PM EDT

AtaiBeckley (ATAI) Operating Margin Growth (1y) (2022 - 2026)

Analysis

AtaiBeckley (ATAI) Operating Margin Growth (1y) (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn -143.00
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 78.00
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn 1,135.00
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 7,666.00
5 Revolution Medicines 44.02 Bn 44.02 Bn - -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 1,238.00
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 2,002.00
8 Royalty Pharma 28.43 Bn 27.59 Bn - -1,651.00
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 29,091.00
10 AtaiBeckley 1.61 Bn 1.61 Bn - 5.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 92,459.00
Mar 31, 2026 -192,913.00
Sep 30, 2025 5.27 Mn
Jun 30, 2025 590,952.00
Dec 31, 2024 -6.58 Mn
Sep 30, 2024 -2.57 Mn
Jun 30, 2024 909,988.00
Dec 31, 2023 -8.76 Mn
Sep 30, 2023 12.93 Mn
Jun 30, 2023 227,382.00
Dec 31, 2022 -7.92 Mn
Sep 30, 2022 -14.76 Mn